Analysis of the effects of perfluorooctane sulfonate on COPD using network toxicology and molecular docking

Chenwen Peng1,2, Jingyan Wei1,2, Wuxia Chen1,2

  • 1Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine, Zhongshan 528400, China.

Iscience
|September 25, 2025
PubMed

Insights

Perfluorooctane sulfonate (PFOS) exposure is linked to chronic obstructive pulmonary disease (COPD) pathogenesis. Key proteins targeted by PFOS disrupt inflammatory and cellular pathways, suggesting new therapeutic strategies for respiratory disorders.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pulmonology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a major global health burden.
  • Environmental pollutants, such as perfluorooctane sulfonate (PFOS), are increasingly implicated in respiratory diseases.
  • Understanding the molecular mechanisms linking PFOS to COPD is crucial for developing effective interventions.

Purpose of the Study:

  • To elucidate the pathogenic mechanisms of PFOS in COPD using network toxicology.
  • To identify key molecular targets and pathways affected by PFOS exposure in COPD.
  • To explore potential therapeutic targets for PFOS-induced respiratory disorders.

Main Methods:

  • Integrated multiple biological databases to identify PFOS-related targets in COPD.
  • Constructed and analyzed protein-protein interaction networks to identify key proteins.
  • Performed functional enrichment analysis (including GSEA) and molecular docking studies.

Main Results:

  • Identified 158 PFOS-related targets in COPD, with EGFR, ESR1, GRB2, HSP90AA1, and SRC as central proteins.
  • Functional analysis revealed PFOS targets key pathways in airway inflammation, oxidative stress, and immune regulation.
  • Molecular docking confirmed high-affinity binding of PFOS to core targets, suggesting dysregulation of cellular processes.

Conclusions:

  • PFOS significantly contributes to COPD pathogenesis by disrupting inflammatory responses, oxidative balance, and cellular proliferation.
  • Key proteins like EGFR and SRC are critical mediators of PFOS toxicity in COPD.
  • These findings offer novel molecular insights and potential therapeutic targets for managing environmental pollutant-aggravated respiratory diseases.